Home » Business » Manufacturing
Drug firms partner
By Ding Yining |
April 22, 2011, Friday
|
Print Edition
Print Edition
SHANGHAI Pharmaceutical Co yesterday said it has signed a strategic partnership agreement with Pfizer to pursue potential business opportunities in China.
The two parties will leverage each other's strengths to combine Pfizer's global capabilities in developing innovative drugs and the Chinese firm's extensive reach in the country.
They also plan to explore future cooperation opportunities in research and development, manufacturing, equity investment and distribution.
The two parties will leverage each other's strengths to combine Pfizer's global capabilities in developing innovative drugs and the Chinese firm's extensive reach in the country.
They also plan to explore future cooperation opportunities in research and development, manufacturing, equity investment and distribution.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
